Decreasing referrals to transient ischaemic attack clinics during the COVID-19 outbreak: results from a multicentre

Lucio D'Anna1,2, Ambreen Sheikh3, Raj Bathula4

  • 1Division of Brain Sciences, Imperial College London, London, UK l.danna@imperial.ac.uk.

BMJ Open
|October 25, 2020
PubMed

Insights

The COVID-19 pandemic caused a 28.6% drop in transient ischaemic attack (TIA) referrals to North West London clinics. This study highlights a significant decrease in TIA referrals during the pandemic.

Area of Science:

  • Neurology
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic has significantly impacted healthcare services, including stroke care, leading to reduced hospital admissions.
  • Transient ischaemic attack (TIA) clinics are crucial for rapid assessment and management of stroke risk.

Purpose of the Study:

  • To investigate the impact of the COVID-19 pandemic on referral rates to TIA clinics in North West London.
  • To quantify the change in TIA referrals during the pandemic compared to the previous year.

Main Methods:

  • A 100% response rate online survey was sent to TIA clinic leads in North West London in May 2020.
  • The survey collected data on the number of suspected TIA referrals between March 1 and April 30, 2020 (COVID-19 period) and March 1 and April 30, 2019.

Main Results:

  • TIA clinics in North West London received 440 referrals during the COVID-19 period, a 28.6% decrease from 616 referrals in the same period in 2019.
  • Referrals in April 2020 saw a more substantial decline of 40.1% compared to April 2019.

Conclusions:

  • The COVID-19 pandemic significantly reduced referrals for suspected TIA to rapid access outpatient clinics in North West London.
  • Further research is necessary to validate these findings and understand cerebrovascular disease incidence during the pandemic.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
125
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
114
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
500
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
235